Verywell Health on MSN
Experimental treatments for type 2 diabetes
Medically reviewed by Jane Kim, MD Key Takeaways Mounjaro is the first dual GIP and GLP-1 agonist medication approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback